912790-59-1
912790-59-1
Chemical Structure
Wnt/β-catenin agonist 3
- CAS No.: 912790-59-1
- Formula:C16H15ClN4O2
- Molecular Weight:330.77
IUPAC Name: N-(3-(1H-imidazol-1-yl)propyl)-5-(4-chlorophenyl)isoxazole-3-carboxamide
InChIKey: KMPHWAGSDPATHS-UHFFFAOYSA-N
SMILES: O=C(C1=NOC(C2=CC=C(Cl)C=C2)=C1)NCCCN3C=CN=C3
Biological Activity: Wnt/β-catenin agonist 3 (compound 98) is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 can be used for the research of osteoporosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Wnt/β-catenin agonist 3 | 99.87% | Wnt/β-catenin agonist 3 (compound 98) is a Wnt/β-catenin signalling pathway agonist. Wnt/β-catenin agonist 3 can be used for the research of osteoporosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SKL2001 (GMP) | SKL2001 (GMP) is SKL2001 (HY-101085) produced by using GMP guidelines. SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
ISX-1 | 98.05% | ISX-1 is an isoxazole. ISX-1 has anti-adipogenic and pro-osteogenic activities. ISX-1 can be used for the research of osteopenia and osteoporosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PY-60 | 99.54% | PY-60 is a robust and specific activator of YAP transcriptional activity that targets annexin A2 (ANXA2) with a Kd of 1.4 µM. PY-60 directly binds to ANXA2 and antagonizes its normal cellular function of repressing YAP activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
ISX-3 | 99.68% | ISX-3 is a potent anti-adipogenic and pro-osteogenic agent. ISX-3 increases the expression of PPARγ. ISX-3 has the potential for the research of osteopenia and osteoporosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Wnt/β-catenin agonist 4 | 99.68% | Wnt/β-catenin agonist 4 (Derivative 83) is an agonist of Wnt that activates Wnt/β-catenin signal transmission. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CFTR corrector 11 | 99.80% | CFTR corrector 11 (compound 133) is a CFTR corrector. CFTR corrector 11 can be used for the study of cystic fibrosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
HDAC-IN-55 | 98.02% | HDAC-IN-55(8j) is a small molecular compound that can increase the expression of E-cadherin and inhibit the proliferation of cancer cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
E-Cadherin activator-1 | 99.15% | E-cadherin activator-1 (Compound 13m) is an E-Cadherin activator. E-cadherin activator-1 can be used in the study of colorectal carcinoma. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-(4-(1H-Pyrazol-1-yl)butyl)-5-(furan-2-yl)isoxazole-3-carboxamide | N-(4-(1H-Pyrazol-1-yl) butyl)-5-(furan-2-yl) isoxazole-3-carboxamide is a cell culture medium component used for the long-term expansion of granulocyte/macrophage progenitor cells in culture. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
CFTR corrector 17 | 98.05% | CFTR corrector 17 is an isoxazole compound and CFTR modulator. CFTR corrector 17 can be used for the research of cystic fibrosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
